Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CCCS +15.2%, RDDT +14.5%, FLGT +13.7%, IRTC +13.4% (also partnership with Lucem Health), CPS +13.3%, APPF +12.6% (also names new CFO), WEAV +12.3%, ATEC +11.4%, BIO +10.8%, TILE +9.4%, BOOT +8.2%, NVT +7.8%, WK +7.6%, HURN +6% (also acquires Treliant), AVNT +5.8%, PSO +5.6%, SPXC +5.5%, SVV +5.4%, FIVN +5.3% (also CEO to retire), BFAM +5.2%, TREE +5.2%, LOCO +5.2%, BJRI +4.7%, LEG +4.1%, MGA +4.1%, SNCY +4%, AMH +3.8%, KMB +3.3%, DXC +3%, RKT +2.9%, NOG +2.8%, CUBE +2.7%, SM +2.7%, FSLR +2.3%, NVST +2.3%, ATR +2%, FTS +2%, CLX +1.9%, AAPL +1.7%, ZEUS +1.6%, COHU +1.5%, CNH +1.5%, FBIN +1.3%, EXPO +1.3%, HTGC +1.2%, PRO +1%
Other news:
- FDMT +38% (results from the SPECTRA clinical trial)
- NTZ +9% (CEO resigns)
- LENZ +7.5% (FDA approves VIZZ 1.44%)
- UTHR +5.9% (will enter into two Accelerated Share Repurchase agreements with Citibank, N.A. to repurchase an aggregate $1 bln of UTHR common stock)
- AREN +3.9% (authorizes new 3 mln share repurchase program)